Now that Perrigo Company PLC has divested its Rx generics business, expanded its portfolio into birth control and got approval for its first US OTC switch and national brand, it’s time for the next step in its growth plan, says president and CEO Murray Kessler.
“We said we would start growing this company, double-digit and earnings double-digits this year, and this is the year to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?